Clyde, North Carolina Clinical Trials

A listing of Clyde, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 19 clinical trials
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

This phase III trial studies how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer that has spread to other parts of the body. Vitamin D3 helps the body use calcium and phosphorus to make strong bones and teeth. Drugs used in chemotherapy, …

metastasis
fluorouracil
metastatic colorectal adenocarcinoma
liver metastasis
platelet count
AdventHealth Infusion Center Haywood
 (0.0 away) Contact site
  • 72 views
  • 27 Jul, 2021
  • +978 other locations
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.

metastasis
paclitaxel
pemetrexed
gemcitabine
pembrolizumab
AdventHealth Infusion Center Haywood
 (0.0 away) Contact site
  • 1103 views
  • 04 Aug, 2021
  • +1138 other locations
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

This phase III trial studies combination chemotherapy and atezolizumab to see how well it works compared with combination chemotherapy alone in treating patients with stage III colon cancer and deficient deoxyribonucleic acid (DNA) mismatch repair. Drugs used in combination chemotherapy, such as oxaliplatin, leucovorin calcium, and fluorouracil, work in different …

investigational agent
metastasis
hysterectomy
colon cancer
fluorouracil
AdventHealth Infusion Center Haywood
 (1.9 away) Contact site
  • 1047 views
  • 01 Aug, 2021
  • +589 other locations
Cediranib Maleate and Olaparib or Standard Chemotherapy in Treating Patients With Recurrent Platinum-Resistant or -Refractory Ovarian Fallopian Tube or Primary Peritoneal Cancer

This randomized phase II/III trial studies how well cediranib maleate and olaparib work when given together or separately, and compares them to standard chemotherapy in treating patients with ovarian, fallopian tube, or primary peritoneal cancer that has returned (recurrent) after receiving chemotherapy with drugs that contain platinum (platinum-resistant) or continued …

topotecan
thyroid dysfunction
metastasis
paclitaxel
cediranib
AdventHealth Infusion Center Haywood
 (0.0 away) Contact site
  • 1729 views
  • 02 Aug, 2021
  • +211 other locations
Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer

This phase III trial studies how well pembrolizumab works in treating patients with bladder cancer that has spread into the deep muscle of the bladder wall (muscle-invasive) or urothelial cancer that has spread from where it started to nearby tissue or lymph nodes (locally advanced). Monoclonal antibodies recognizing and blocking …

AdventHealth Infusion Center Haywood
 (1.9 away) Contact site
  • 836 views
  • 04 Aug, 2021
  • +758 other locations
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial enrolls participants for …

mucinous adenocarcinoma
ACTH
metastatic malignancy
hysterectomy
oophorectomy
AdventHealth Infusion Center Haywood
 (0.0 away) Contact site
  • 6047 views
  • 04 Aug, 2021
  • +814 other locations
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

This randomized phase III trial studies how well olanzapine with or without fosaprepitant work in preventing chemotherapy induced nausea and vomiting in cancer patients receiving chemotherapy that causes vomiting. Olanzapine and fosaprepitant dimeglumine may help control nausea and vomiting in patients during chemotherapy. Olanzapine is usually given in combination with …

bilateral oophorectomy
metastasis
treatment regimen
cyclophosphamide
emetics
AdventHealth Infusion Center Haywood
 (0.0 away) Contact site
  • 109 views
  • 29 Jul, 2021
  • +603 other locations
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

This phase II/III trials studies whether maintenance immunotherapy (nivolumab) following definitive treatment with radiation and chemotherapy (cisplatin) result in significant improvement in overall survival (time being alive) and progression-free survival (time being alive without cancer) for patients with intermediate risk human papillomavirus (HPV) positive oropharynx cancer (throat cancer) that has …

AdventHealth Infusion Center Haywood
 (0.0 away) Contact site
  • 135 views
  • 04 Aug, 2021
  • +539 other locations
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer The PDIGREE Study

This phase III trial compares the usual treatment (treatment with ipilimumab and nivolumab followed by nivolumab alone) to treatment with ipilimumab and nivolumab, followed by nivolumab with cabozantinib in patients with untreated renal cell carcinoma that has spread to other parts of the body. The addition of cabozantinib to the …

cabozantinib
metastasis
ipilimumab
liver metastasis
pembrolizumab
AdventHealth Infusion Center Haywood
 (0.0 away) Contact site
  • 157 views
  • 04 Aug, 2021
  • +680 other locations
S1803 Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Patients are enrolled to screening (Reg Step 1) prior to or after ASCT but prior to Reg Step 2. Patients are followed until they will begin Maintenance and then registered to Reg Step 2 (first randomization). Patients are randomized between Lenalidomide for 2 years and Lenalidomide + Daratumumab/rHuPH20. After 2 …

daratumumab
aspirin
lenalidomide
induction therapy
heparin
AdventHealth Infusion Center Haywood
 (1.9 away) Contact site
  • 86 views
  • 07 Mar, 2021
  • +550 other locations